Delivery Order SPE2DB22D1202-SPE2DB24FUVX3
Award Date 4/5/24
Potential Completion Date 4/8/24
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order worth $1,250.40 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of 120 tablets of the pharmaceutical product CONTRAVE ER 8-90 MG. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as the primary contract vehicle for AmerisourceBergen to deliver pharmaceutical products and medical supplies to DLA Troop...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of Contrave ER 8-90 mg tablets. The contract, valued at $1,814.81, has an ultimate completion date of April 2, 2024. AmerisourceBergen Drug Corp is the prime contractor and this award is associated with a $999,999,999.00 indefinite delivery contract (IDC) the company holds with DLA, which serves as the primary...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order valued at $13,675.32 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical distribution company. The delivery order is for CONTRAVE ER 8-90 MG TABLET 120S and has a completion date of March 8, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor on this award, which is not designated as a set-aside...
- The U.S. Defense Logistics Agency (DLA) awarded a $6,291.90 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the for-profit AmerisourceBergen Corporation. The order is for the pharmaceutical product CONTRAVE ER 8-90 MG TABLET 120S and has an ultimate completion date of April 15, 2024. This delivery order is under AmerisourceBergen Drug Corp's larger $999,999,999.00 indefinite delivery contract with DLA to provide pharmaceutical products and medical...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $3,351.80 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the provision of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product, with a completion date of February 5, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is the prime contractor...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,045.63 to AmerisourceBergen Drug Corp for the supply of Contrave ER 8-90 mg tablets (120 count). The contract is a firm fixed price delivery order with an ultimate completion date of June 2, 2025, and represents a non-competitive award under DLA's existing pharmaceutical supply framework. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company, for the provision of Contrave ER 8-90 mg tablets. The Delivery Order, valued at $6,752.60, was awarded on a Firm Fixed Price basis without any set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. This single-award...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,515.09 delivery order for Contrave ER 8-90 mg tablets (120-count units) on August 19, 2025, with an ultimate completion date of August 20, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work will be performed at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,654.69 to AmerisourceBergen Drug Corp for Contrave ER 8-90 mg tablets (120-count supply), with a firm fixed price structure and an ultimate completion date of December 15, 2025. This non-set-aside, competitively awarded contract was issued on December 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,825.61 firm fixed-price delivery order is for the supply of Contrave ER 8-90 mg tablets, a medication used for weight management. The contract has an ultimate completion date of July 19, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...